Delivery Order SPE2DB24D2010-SPE2DB25FABEG
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $26,313.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract does not include a set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $57,859.44 under a Firm Fixed Price contract type. This is a non-set-aside award, reflecting AmerisourceBergen's demonstrated capability to compete for federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,735.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,090.75 delivery order to AmerisourceBergen Drug Corp for supply of Dupixent 300 mg/2 ml syringes on July 30, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $57,226.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, with performance of work taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $23,362.12 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on a firm fixed price basis. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of September 12, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $43,410.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes with an ultimate completion date of September 10, 2025. The contract, executed on September 9, 2025, carries no set-aside designation and represents a competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,643.27 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Dupixent (dupilumab) 300 mg/2 ml syringes on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, valued at $1,709.46, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABEGDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,250.86 on September 12, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. The company's federal contracting demonstrates strong capability in meeting defense medical procurement requirements across a broad spectrum of therapeutic domains and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 9/12/25 |